Filing Details

Accession Number:
0001181431-14-026871
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-16 18:18:15
Reporting Period:
2014-07-16
Filing Date:
2014-07-16
Accepted Time:
2014-07-16 18:18:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1392380 Gevo Inc. GEVO Industrial Organic Chemicals (2860) 870747704
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1512143 Michael Christopher Ryan Gevo, Inc., 345 Inverness Drive South
Building C, Suite 310
Englewood CO 80112
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-07-15 2,248 $0.81 370,688 No 4 S Direct
Common Stock Disposition 2014-07-16 2,119 $0.78 368,568 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares were sold to satisfy certain tax obligations of the reporting person triggered by the vesting of such restricted stock shares. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading adopted May 28, 2014.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.79 to $.82, inclusive. The reporting person undertakes to provide to Gevo, Inc., any security holder of Gevo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $.76 to $.79, inclusive. The reporting person undertakes to provide to Gevo, Inc., any security holder of Gevo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4